Search
Understanding common challenges in childhood cancer treatment
- OPACC
- Jan 15
- 1 min read
Lorna Rothery interviewed Dr John Glod from the National Cancer Institute, which is part of the National Institutes of Health, about the main challenges in childhood cancer treatment and the advancements in care.
Recent Posts
See AllThe FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...
A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic...
Comentários